MR编号 | FR/H/0607/001 |
---|
药品名称 | Microlax 5ml Rectal Solution |
---|
活性成分 | - sodium citrate 0.45 g/dose
- SODIUM LAURYL SULFOACETATE 0.06 g/dose
- SORBITOL 4.46 g/dose
|
---|
剂型 | Rectal solution |
---|
上市许可持有人 | JOHNSON & JOHNSON SANTE BEAUTE France
1 RUE CAMILLE DESMOULINS
92130 ISSY LES MOULINEAUX
FRANCE |
---|
参考成员国 - 产品名称 | France (FR) Sorbitol Citrate et Laurilsulfoacetate de Sodium Johnson & Johnson, solution rectale |
---|
互认成员国 - 产品名称 | - Italy (IT)
- Greece (GR)
MICROLAX - Poland (PL)
Microlax - Hungary (HU)
MICROLAX végbéloldat - Bulgaria (BG)
Microlax 5ml Rectal Solution - Cyprus (CY)
microlax rectal solution - Romania (RO)
- Slovakia (SK)
Microlax 625 mg/90 mg/9 mg/ml rektálny roztok - Slovenia (SI)
- Croatia (HR)
Microlax 4,465 g/0,45 g/0,0645 g otopina za rektum
|
---|
许可日期 | 2017/08/11 |
---|
最近更新日期 | 2024/06/26 |
---|
药物ATC编码 | - A06AG11 sodium lauryl sulfoacetate, incl. combinations
|
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Non Prescription (including OTC)
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|